MYD88 and chronic myelogenous leukemia, BCR-ABL1 positive: Compared with AGE-BSA, however, neither MGO-BSA, nor CML-BSA at 30 μg/mL induced MD2-TLR4-MyD88 interaction in MPMs and H9C2 cells (Supplementary Fig. 23a–c).